Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (141-150 of 194) with videos related to

Pageof 20
Sort By:
Dermatology Practical & Conceptual|November 14, 2025
Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian CohortAlessandro Giunta, Maria Esposito, Elena Campione, et al.
Vaccines|April 28, 2023
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 14, 2020
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patientsClara De Simone, Laura Calabrese, Anna Balato, et al.
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 16, 2023
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective studyMartina Dragotto, Eugenio Capalbo, Alessandra Cartocci, et al.
Drugs & Aging|July 23, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology|November 7, 2024
Risankizumab in very elderly patients in real-world practiceElisa Lorenzoni, Antonella Di Cesare, Elia Rosi, et al.
Journal of the American Academy of Dermatology|February 22, 2019
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective studyTiago Torres, Anna Balato, Curdin Conrad, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort StudyFlaminia Antonelli, Elena Ippoliti, Elia Rosi, et al.
Pageof 20

Showing results (141-150 of 194) with videos related to

Sort By:
Pageof 20
Dermatology Practical & Conceptual|November 14, 2025
Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian CohortAlessandro Giunta, Maria Esposito, Elena Campione, et al.
Vaccines|April 28, 2023
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 14, 2020
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patientsClara De Simone, Laura Calabrese, Anna Balato, et al.
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 16, 2023
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective studyMartina Dragotto, Eugenio Capalbo, Alessandra Cartocci, et al.
Drugs & Aging|July 23, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology|November 7, 2024
Risankizumab in very elderly patients in real-world practiceElisa Lorenzoni, Antonella Di Cesare, Elia Rosi, et al.
Journal of the American Academy of Dermatology|February 22, 2019
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective studyTiago Torres, Anna Balato, Curdin Conrad, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort StudyFlaminia Antonelli, Elena Ippoliti, Elia Rosi, et al.
Pageof 20